Uptake of gamma-valerolactone-detection of gamma-hydroxyvaleric acid in human urine samples

Journal of Analytical Toxicology

Volumn 37, Issue 4, 2013, Pages 250-254

  Andresen Streichert, H ^a   Jungen, H ^a   Gehl, A ^a   Muller A ^a   Iwersen Bergmann, S ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYVALERIC ACID; GAMMA VALEROLACTONE; UNCLASSIFIED DRUG; VALERIC ACID;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOASSAY; MASS FRAGMENTOGRAPHY; MEDICAL EXAMINATION; MUSCLE WEAKNESS; SEXUAL CRIME; URINALYSIS;

ADULT; CALIBRATION; CHROMATOGRAPHY, GAS; FEMALE; HUMANS; LACTONES; MALE; MASS SPECTROMETRY; RAPE; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; SUBSTANCE-RELATED DISORDERS; VALERATES;

EID: 84876028295     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkt013     Document Type: Article

References (20)

1. U.S. Department of Justice. (2003) Information Bulletin: GHB Analogs. GBL, BD, GHV, and GVL. In Microgram Bulletin May, The Drug Enforcement Administration Washington, DC. pp. 98-102.
2. Marinetti, L., LeBeau, M. (2010) The use of GHB and analogs to facilitate sexual assault. Forensic Science Reviews, 22, 41.
3. Carter, L., Chen, W., Wu, H., Mehta, A., Hernandez, R., Ticku, M. et al. (2005) Comparison of the behavioral effects of gammahydroxybutyric acid (GHB) and its 4-methyl-substituted analog, gamma-hydroxyvaleric acid (GHV). Drug and Alcohol Dependence, 78, 91-99.
4. Palmer, R. (2004) gamma-butyrolactone and 1,4-butanediol: Abused analogues of gamma-hydroxybutyrate. Toxicology Reviews, 23, 21-31.
5. Fishbein, W., Bessman, S. (1966) Purification and properties of an enzyme in human blood and rat liver microsomes catalyzing the formation and hydrolysis of gamma-lactones. II. Metal ion effects, kinetics, and equilibra. Journal of Biological Chemistry, 241, 4842-4847.
6. Bourguignon, J., Schoenfelder, A., Schmitt, M., Wermuth, V., Hechler, V., Charlier, B. et al. (1988) Analogues of gammahydroxybutyric acid. Synthesis and binding studies. Journal of Medicinal Chemistry, 31, 893-897.
7. Marinetti, L.J., Isenschmid, D.S., Hepler, B.R., Kanluen, S. (2005) Analysis of GHB and 4-methyl-GHB in postmortem matrices after long-term storage. Journal of Analytical Toxicology, 29, 41-47.
8. Brenneisen, R., ElSohly, M.A., Murphy, T.P., Passarelli, J., Russmann, S., Salamone, S.J. et al. (2004) Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects. Journal of Analytical Toxicology, 28, 625-630.
9. Johansen, S., Windberg, C. (2011) Simultaneous determination of g-hydroxybutyrate (GHB) and its analogues (GBL, 1.4-BD, GVL) in whole blood and urine by liquid chromatography coupled to tandem mass spectrometry. Journal of Analytical Toxicology, 35, 8-14.
10. Mercer, J., Oldfield, L., Hoffman, K., Shakleya, D., Bell, S. (2007) Comparative analysis of gamma-hydroxybutyrate and gammahydroxyvalerate using GC/MS and HPLC. Journal of Forensic Sciences, 52, 383-388.
11. EMCDDA (2008) Sexual assaults facilitated by drugs or alcohol. http://www.emcdda.europa.eu/html.cfm/index7291EN.html
12. Lora-Tamayo, C., Tena, T., Rodri{dotless}́guez, A., Sancho, J., Molina, E. (2003) Intoxication due to 1,4 butanediol. Forensic Science International, 133, 256-259.
13. Lenz, D., Rothschild, M., Kroener, L. (2008) Intoxications due to ingestion of gamma-butyrolactone: Organ distribution of gammahydroxybutyric acid and gamma-butyrolactone. Therapeutic Drug Monitoring, 30, 755-761.
14. Andresen, H., Sprys, N., Schmoldt, A., Mueller, A., Iwersen-Bergmann, S. (2010) Gamma-hydroxybutyrate in urine and serum: additional data supporting current cut-off recommendations. Forensic Science International, 200, 93-99.
15. Kerrigan, S. (2002) In vitro production of gamma-hydroxybutyrate in antemortem urine samples. Journal of Analytical Toxicology, 26, 571-574.
16. Paul, L., Mußhoff, F., Aebi, B., Auwärter, V., Krämer, T., Peters, F. et al. (2009) Richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen (Guidelines for quality assurance in forensic-toxicological analyses).
17. Shah, V., Midha, K., Dighe, S., McGilveray, I., Skelly, J., Yacobi, A. et al. (1992) Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic Studies. Pharmaceutical Research, 9, 588-592.
18. Shah, V., Midha, K., Findlay, J., Hill, H., Hulse, J., McGilveray, I. et al. (2000) Bioanalytical method validation-A revisit with a decade of progress. Pharmaceutical Research, 17, 1551-1557.
19. Deutsche Gesellschaft fü r Rechtsmedizin, Deutsche Gesellschaft fü r Verkehrsmedizin, Deutsche Gesellschaft fü r Toxikologie und Forensische Chemie (2007) Richtlinien zur Bestimmung der Blutalkoholkonzentration im Blut (BAK) fü r forensische Zwecke. Blutalkohol, 44, 273-282.
20. Deichmann, W., Hirose, R., Witherup, S. (1945) Observations on the effects of gamma-valero-lactone upon experimental animals. Journal of Industrial Hygiene and Toxicology, 27, 263-268.